AT108 - Asgard Therapeutics
https://www.liebertpub.com/doi/epub/10.1089/hum.2024.63331.oab
 
E Ascic1, 2 F Åkerström3; M Sreekumar Nair1, 2; A Rosa3; I Kurochkin1, 2; O Zimmermannova1, 2; X Catena1, 2, 3; N Rotankova4; C Veser4; M Rudnik4; T Ballocci1, 2; T Schärer3; X Huang3 M de Rosa Torres1, 2; E Renaud3; M Velasco Santiago5 Ö Met5, 6; D Askmyr7, 8; M Lindstedt9; L Greiff7, 8; LA Ligeon4; I Agarkova4; IM Svane5; CF Pires3; FF Rosa3; CF Pereira1, 2, 3, 10
 
Oct 31, 2024
 
Prev Next